Showing results (1101-1110 of 1,468) with videos related to

Sort By:
Pageof 147
Journal of Pain and Symptom Management|July 17, 2017
Web-Based Tailored Psychoeducation for Breast Cancer Patients at the Onset of the Survivorship Phase: A Multicenter Randomized Controlled TrialJolien M Admiraal, Annette W G van der Velden, Jenske I Geerling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemiaSabine L A Plasschaert, Eveline S J M de Bont, Marike Boezen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 15, 2018
Micro-computed tomography (micro-CT) for intraoperative surgical margin assessment of breast cancer: A feasibility study in breast conserving surgerySi-Qi Qiu, Monique D Dorrius, Steven J de Jongh, et al.
Science (New York, N.Y.)|December 7, 2011
The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescenceJorge Ivan Alvarez, Aurore Dodelet-Devillers, Hania Kebir, et al.
Pharmacology & Therapeutics|December 3, 2014
Targeting breast cancer through its microenvironment: current status of preclinical and clinical research in finding relevant targetsH H Nienhuis, S B M Gaykema, H Timmer-Bosscha, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 16, 2003
Interferon-beta blocks infiltration of inflammatory cells and reduces infarct volume after ischemic stroke in the ratWouter B Veldhuis, Joris W Derksen, Sarah Floris, et al.
The Lancet. Global Health|October 2, 2022
Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forwardKristina Jenei, Zeba Aziz, Christopher Booth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2016
Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 StudyJames C Yao, Marianne Pavel, Catherine Lombard-Bohas, et al.
Pageof 147